scholarly article | Q13442814 |
P2093 | author name string | R B Gaynor | |
S H Ou | |||
E J Paulssen | |||
L F Garcia-Martínez | |||
P2860 | cites work | Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc | Q24294647 |
A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins | Q24299387 | ||
Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence | Q24300878 | ||
Two distinct transcription factors that bind the immunoglobulin enhancer microE5/kappa 2 motif | Q24305878 | ||
The myoD Gene Family: Nodal Point During Specification of the Muscle Cell Lineage | Q24310740 | ||
The adenovirus major late transcription factor USF is a member of the helix-loop-helix group of regulatory proteins and binds to DNA as a dimer | Q24313060 | ||
Human immunodeficiency virus type 1 transactivator protein, tat, stimulates transcriptional read-through of distal terminator sequences in vitro | Q36398874 | ||
Adenovirus early region 3 promoter regulation by E1A/E1B is independent of alterations in DNA binding and gene activation of CREB/ATF and AP1. | Q36805319 | ||
Effects of long terminal repeat mutations on human immunodeficiency virus type 1 replication | Q36830870 | ||
Factors involved in specific transcription by mammalian RNA polymerase II: purification, genetic specificity, and TATA box-promoter interactions of TFIID. | Q36846156 | ||
Roles of TFIID in transcriptional initiation by RNA polymerase II. | Q37366750 | ||
The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation | Q37506941 | ||
Mutagenesis of the myogenin basic region identifies an ancient protein motif critical for activation of myogenesis | Q37541258 | ||
HIV-1 core promoter lacks a simple initiator element but contains a bipartite activator at the transcription start site. | Q38317454 | ||
The human immunodeficiency virus type 1 long terminal repeat specifies two different transcription complexes, only one of which is regulated by Tat | Q38320497 | ||
Holo-TFIID supports transcriptional stimulation by diverse activators and from a TATA-less promoter | Q38325574 | ||
Sequence-specific DNA binding by the c-Myc protein | Q38338266 | ||
The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation | Q38341599 | ||
Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation | Q38345116 | ||
Functional domains required for tat-induced transcriptional activation of the HIV-1 long terminal repeat | Q38346354 | ||
Three in one and one in three: it all depends on TBP. | Q40870160 | ||
Functional heterogeneity of mammalian TATA-box sequences revealed by interaction with a cell-specific enhancer | Q41199282 | ||
Family of proteins that interact with TFIID and regulate promoter activity | Q42473645 | ||
Definition of multiple, functionally distinct TATA elements, one of which is a target in the hsp70 promoter for E1A regulation | Q42501525 | ||
The functional BPV-1 E2 trans-activating protein can act as a repressor by preventing formation of the initiation complex | Q42613510 | ||
Largest subunit of Drosophila transcription factor IID directs assembly of a complex containing TBP and a coactivator. | Q44826917 | ||
Structural arrangements of transcription control domains within the 5'-untranslated leader regions of the HIV-1 and HIV-2 promoters | Q46329660 | ||
Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. | Q48365300 | ||
Transcription factor AP-4 contains multiple dimerization domains that regulate dimer specificity | Q24337063 | ||
Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro | Q24339646 | ||
Formation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic T cells | Q24563634 | ||
Interactions of HTF4 with E-box motifs in the long terminal repeat of human immunodeficiency virus type 1 | Q24630250 | ||
Purification of a RAS-responsive adenylyl cyclase complex from Saccharomyces cerevisiae by use of an epitope addition method | Q24631695 | ||
Role of SP1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat | Q24645992 | ||
Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat | Q24655684 | ||
Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain | Q27732150 | ||
Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase | Q27860571 | ||
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei | Q27860728 | ||
Functional domains and upstream activation properties of cloned human TATA binding protein | Q28116604 | ||
Cooperative interaction of an initiator-binding transcription initiation factor and the helix-loop-helix activator USF | Q28252370 | ||
A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL | Q28254962 | ||
Consequences of heteromeric interactions among helix-loop-helix proteins | Q28265557 | ||
Cellular transcription factors involved in the regulation of HIV-1 gene expression | Q28272528 | ||
Isolation of coactivators associated with the TATA-binding protein that mediate transcriptional activation | Q28303864 | ||
Id proteins Id1 and Id2 selectively inhibit DNA binding by one class of helix-loop-helix proteins | Q28508665 | ||
Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product | Q29615049 | ||
Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection | Q29617433 | ||
An inducible transcription factor activates expression of human immunodeficiency virus in T cells | Q29618434 | ||
Molecular cloning and functional analysis of Drosophila TAF110 reveal properties expected of coactivators | Q29620376 | ||
HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation | Q29620799 | ||
HIV-1 Tat protein trans-activates transcription in vitro | Q30411837 | ||
An inhibitory domain of E12 transcription factor prevents DNA binding in E12 homodimers but not in E12 heterodimers | Q33332420 | ||
Functional binding of the "TATA" box binding component of transcription factor TFIID to the -30 region of TATA-less promoters | Q33611452 | ||
Contribution of the TATA motif to Tat-mediated transcriptional activation of human immunodeficiency virus gene expression | Q33936851 | ||
Human transcription factor USF stimulates transcription through the initiator elements of the HIV-1 and the Ad-ML promoters | Q34043082 | ||
Unique TATA-binding protein-containing complexes and cofactors involved in transcription by RNA polymerases II and III | Q34055015 | ||
Repression of HIV-1 transcription by a cellular protein | Q34092073 | ||
Multiple factors required for accurate initiation of transcription by purified RNA polymerase II. | Q34287520 | ||
Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5' sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system | Q34296022 | ||
tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185. | Q34975992 | ||
Advances in RNA polymerase II transcription | Q35673499 | ||
HIV-1 Tat protein promotes formation of more-processive elongation complexes | Q35937536 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | TATA-box binding protein | Q2480972 |
virology | Q7215 | ||
E-box binding | Q14864477 | ||
transcription factor 3 | Q21111604 | ||
Transcription factor AP-4 | Q21133097 | ||
P304 | page(s) | 7188-7199 | |
P577 | publication date | 1994-11-01 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Role of flanking E box motifs in human immunodeficiency virus type 1 TATA element function | |
P478 | volume | 68 |
Q33613718 | A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter |
Q24316196 | AP4 encodes a c-MYC-inducible repressor of p21 |
Q35859223 | Activation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F. |
Q41935503 | CTGC motifs within the HIV core promoter specify Tat-responsive pre-initiation complexes |
Q24317451 | Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs |
Q24337403 | Complementary quantitative proteomics reveals that transcription factor AP-4 mediates E-box-dependent complex formation for transcriptional repression of HDM2 |
Q53692218 | Distinctive variation in the U3R region of the 5' Long Terminal Repeat from diverse HIV-1 strains. |
Q34277738 | Down-regulation of AP-4 inhibits proliferation, induces cell cycle arrest and promotes apoptosis in human gastric cancer cells |
Q42563241 | E box motifs as mediators of proviral latency of human retroviruses. |
Q40017514 | Helix-loop-helix transcription factors mediate activation and repression of the p75LNGFR gene |
Q38293063 | Human immunodeficiency virus type 1 TAR element revertant viruses define RNA structures required for efficient viral gene expression and replication |
Q35862161 | Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity. |
Q35222092 | Identification and functional analysis of a second RBF-2 binding site within the HIV-1 promoter |
Q24671522 | Interactions of thyroid hormone receptor with the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and the HIV-1 Tat transactivator |
Q64061957 | MYC Oncogene Contributions to Release of Cell Cycle Brakes |
Q33753132 | Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A Review |
Q33783417 | Naturally occurring human immunodeficiency virus type 1 long terminal repeats have a frequently observed duplication that binds RBF-2 and represses transcription |
Q51401747 | Positive selection of the TRIM family regulatory region in primate genomes. |
Q26797870 | Post-transcriptional gene silencing, transcriptional gene silencing and human immunodeficiency virus |
Q36587864 | Proteomic analysis of early HIV-1 nucleoprotein complexes |
Q39685491 | RNA interference directed against viral and cellular targets inhibits human immunodeficiency Virus Type 1 replication |
Q33785650 | Retinoid-induced repression of human immunodeficiency virus type 1 core promoter activity inhibits virus replication |
Q35874869 | The Epstein-Barr virus EBNA-1 promoter Qp requires an initiator-like element |
Q24312742 | The cellular factor TRP-185 regulates RNA polymerase II binding to HIV-1 TAR RNA |
Q39069527 | Transcription elongation regulator 1 (TCERG1) regulates competent RNA polymerase II-mediated elongation of HIV-1 transcription and facilitates efficient viral replication. |
Q24290811 | Transcription factor AP-4 is a ligand for immunoglobulin-kappa promoter E-box elements |
Q90035728 | Variation in cell-associated unspliced HIV RNA on antiretroviral therapy is associated with the circadian regulator brain-and-muscle-ARNT-like-1 |
Q35034218 | ZASC1 stimulates HIV-1 transcription elongation by recruiting P-TEFb and TAT to the LTR promoter |
Search more.